US Patent Number

9402875

Publication Date

8-2-2016

Abstract

The present invention relates to the use of novel proteins, referred to herein as amidated glial cell line-derived neurotrophic factor (GDNF) peptides (or “Amidated Dopamine Neuron Stimulating peptides (ADNS peptides)”), for treating brain diseases and injuries that result in dopaminergic deficiencies and mitochodrial dysfunction, e.g., reduced complex I enzyme activity.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

13/586,617

Filing Date

08/15/2012

Share

COinS